Scientists test if breakfast changes how your body uses a new pill
NCT ID NCT07404137
Summary
This early study aims to understand how eating a meal affects the way the body absorbs and processes a new combination pill containing two drugs, zibotentan and dapagliflozin. It involves 26 healthy volunteers who will take the pill once on an empty stomach and once after a high-fat meal so researchers can compare the drug levels in their blood. The main goal is to gather basic safety and absorption data to help plan future studies in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGGlendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.